Optic Neuropathy - Pipeline Review, H2 2015

Publisher Name :
Date: 26-Aug-2015
No. of pages: 50
Inquire Before Buying

Global Markets Direct's, ‘Optic Neuropathy - Pipeline Review, H2 2015', provides an overview of the Optic Neuropathy's therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Optic Neuropathy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Optic Neuropathy and special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global therapeutic landscape of Optic Neuropathy

  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities

  • The report reviews key players involved in the therapeutics development for Optic Neuropathy and enlists all their major and minor projects

  • The report summarizes all the dormant and discontinued pipeline projects

  • A review of the Optic Neuropathy products under development by companies and universities/research institutes based on information derived from company and industry-specific sources

  • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages

  • A detailed assessment of monotherapy and combination therapy pipeline projects

  • Coverage of the Optic Neuropathy pipeline on the basis of target, MoA, route of administration and molecule type

  • Latest news and deals relating related to pipeline products

Reasons to buy

  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies

  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

  • Develop strategic initiatives by understanding the focus areas of leading companies

  • Identify and understand important and diverse types of therapeutics under development for Optic Neuropathy

  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

  • Devise corrective measures for pipeline projects by understanding Optic Neuropathy pipeline depth and focus of Indication therapeutics

  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope

  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Optic Neuropathy - Pipeline Review, H2 2015

Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Optic Neuropathy Overview 6
Therapeutics Development 7
Pipeline Products for Optic Neuropathy - Overview 7
Pipeline Products for Optic Neuropathy - Comparative Analysis 8
Optic Neuropathy - Therapeutics under Development by Companies 9
Optic Neuropathy - Therapeutics under Investigation by Universities/Institutes 10
Optic Neuropathy - Pipeline Products Glance 11
Clinical Stage Products 11
Early Stage Products 12
Optic Neuropathy - Products under Development by Companies 13
Optic Neuropathy - Products under Investigation by Universities/Institutes 14
Optic Neuropathy - Companies Involved in Therapeutics Development 15
Inotek Pharmaceuticals Corporation 15
Neurotech Pharmaceuticals, Inc. 16
PharmatrophiX, Inc. 17
Quark Pharmaceuticals, Inc. 18
Regenera Pharma Ltd. 19
Optic Neuropathy - Therapeutics Assessment 20
Assessment by Monotherapy Products 20
Assessment by Target 21
Assessment by Mechanism of Action 23
Assessment by Route of Administration 25
Assessment by Molecule Type 27
Drug Profiles 29
Antibody to Inhibit Sema3A for Glaucoma and Optic Neuropathy - Drug Profile 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
BA-240 - Drug Profile 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
NT-501 - Drug Profile 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
QPI-1007 - Drug Profile 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
RPh-201 - Drug Profile 35
Product Description 35
Mechanism of Action 35
R&D Progress 35
Small Molecule to Inhibit Sema3A for Glaucoma and Optic Neuropathy - Drug Profile 37
Product Description 37
Mechanism of Action 37
R&D Progress 37
Small Molecules for CNS Disorders and Ophthalmology - Drug Profile 38
Product Description 38
Mechanism of Action 38
R&D Progress 38
Small Molecules for Ophthalmology, Cardiovascular, CNS and Metabolic Disorders - Drug Profile 39
Product Description 39
Mechanism of Action 39
R&D Progress 39
Small Molecules to Agonize TrkB for Ophthalmology and Central Nervous System - Drug Profile 41
Product Description 41
Mechanism of Action 41
R&D Progress 41
Synthetic Peptide to Inhibit Connexin for Optic Neuropathy - Drug Profile 42
Product Description 42
Mechanism of Action 42
R&D Progress 42
trabodenoson - Drug Profile 43
Product Description 43
Mechanism of Action 43
R&D Progress 43
Optic Neuropathy - Recent Pipeline Updates 44
Optic Neuropathy - Dormant Projects 47
Optic Neuropathy - Product Development Milestones 48
Featured News & Press Releases 48
Feb 28, 2014: Regenera Pharma has been initiated the Phase IIa study in patients with chronic Ischemic Optic Neuropathy 48
Apr 30, 2011: Regenera Pharma received the final report of its safety study in minipigs and is moving to human studies 48
Appendix 49
Methodology 49
Coverage 49
Secondary Research 49
Primary Research 49
Expert Panel Validation 49
Contact Us 49
Disclaimer 50

List of Tables

Number of Products under Development for Optic Neuropathy, H2 2015 7
Number of Products under Development for Optic Neuropathy - Comparative Analysis, H2 2015 8
Number of Products under Development by Companies, H2 2015 9
Number of Products under Investigation by Universities/Institutes, H2 2015 10
Comparative Analysis by Clinical Stage Development, H2 2015 11
Comparative Analysis by Early Stage Development, H2 2015 12
Products under Development by Companies, H2 2015 13
Products under Investigation by Universities/Institutes, H2 2015 14
Optic Neuropathy - Pipeline by Inotek Pharmaceuticals Corporation, H2 2015 15
Optic Neuropathy - Pipeline by Neurotech Pharmaceuticals, Inc., H2 2015 16
Optic Neuropathy - Pipeline by PharmatrophiX, Inc., H2 2015 17
Optic Neuropathy - Pipeline by Quark Pharmaceuticals, Inc., H2 2015 18
Optic Neuropathy - Pipeline by Regenera Pharma Ltd., H2 2015 19
Assessment by Monotherapy Products, H2 2015 20
Number of Products by Stage and Target, H2 2015 22
Number of Products by Stage and Mechanism of Action, H2 2015 24
Number of Products by Stage and Route of Administration, H2 2015 26
Number of Products by Stage and Molecule Type, H2 2015 28
Optic Neuropathy Therapeutics - Recent Pipeline Updates, H2 2015 44
Optic Neuropathy - Dormant Projects, H2 2015 47

List of Figures

Number of Products under Development for Optic Neuropathy, H2 2015 7
Number of Products under Development for Optic Neuropathy - Comparative Analysis, H2 2015 8
Number of Products under Development by Companies, H2 2015 9
Number of Products under Investigation by Universities/Institutes, H2 2015 10
Comparative Analysis by Clinical Stage Development, H2 2015 11
Comparative Analysis by Early Stage Products, H2 2015 12
Assessment by Monotherapy Products, H2 2015 20
Number of Products by Top 10 Targets, H2 2015 21
Number of Products by Stage and Top 10 Targets, H2 2015 21
Number of Products by Top 10 Mechanism of Actions, H2 2015 23
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2015 23
Number of Products by Top 10 Routes of Administration, H2 2015 25
Number of Products by Stage and Top 10 Routes of Administration, H2 2015 25
Number of Products by Top 10 Molecule Types, H2 2015 27
Number of Products by Stage and Top 10 Molecule Types, H2 2015 27
  • Global (United States, European Union and China) Corneal Implants Market Research Report 2019-2025
    Published: 23-May-2019        Price: US 3280 Onwards        Pages: 114
    In 2019, the market size of Corneal Implants is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period. In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Corneal Implants. This report studies the global market size of Corn......
  • Global Retinoblastoma Treatment Market Size, Status and Forecast 2019-2025
    Published: 22-May-2019        Price: US 3900 Onwards        Pages: 92
    Retinoblastoma is a cancer that starts in the retina, the very back part of the eye. In 2018, the global Retinoblastoma Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Retinoblastoma Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Retinoblastoma Treatment development in Unite......
  • Global Ophthalmic Suspension Market Insights, Forecast to 2025
    Published: 20-May-2019        Price: US 3900 Onwards        Pages: 113
    Ophthalmic Suspension (neomycin and polymyxin B sulfates and hydrocortisone) is a combination of two antibiotics and a steroid used to treat bacterial infections of the eyes. Ophthalmic Suspension is available in generic form. Increasing prevalence of eye diseases across the globe is one of the major factors contributing to the growth of this market. Moreover, increasing geriatric population which are most prone to eye disorders, and growing number of bacterial infections cases in childre......
  • Global Contact Lens Solution Market Professional Survey 2019 by Manufacturers, Regions, Countries, Types and Applications, Forecast to 2024
    Published: 15-May-2019        Price: US 2900 Onwards        Pages: 161
    The Contact Lens Solution market was valued at XX Million US$ in 2018 and is projected to reach XX Million US$ by 2024, at a CAGR of XX% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2024 as the forecast period to estimate the market size for Contact Lens Solution. Global Contact Lens Solution industry market professional research 2014-2024, is a report which provides the details about industry overview, industry chain, market siz......
  • Global Latanoprost Market Professional Survey 2019 by Manufacturers, Regions, Types and Applications, Forecast to 2024
    Published: 14-May-2019        Price: US 2600 Onwards        Pages: 149
    In this report, we analyze the Latanoprost industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2014 to 2019. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions from 2014 to 2019. We also make a predic......
  • Global Contact Lenses and Solutions Market Insights, Forecast to 2025
    Published: 13-May-2019        Price: US 4900 Onwards        Pages: 121
    Contact Lenses and Solutions is a kind of solution that is used to contact lens with the function of cleaning, disinfection, rinsing or preservation; it can also alleviate the eyeball discomfort which caused by wear the contact lens. Contact Lenses and Solutions can direct contact eyeball, so it must be accord with industrial standard. The Japanese regional market is expected to witness immense growth prospects in the Contact Lenses and Solutions segment, owing to circle lenses that are s......
  • Eye drop Liquid Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 08-May-2019        Price: US 3000 Onwards        Pages: 148
    Eye drop Liquid Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Eye drop Liquid industry with a focus on the Chinese market. The report provides key statistics on the market status of the Eye drop Liquid manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-2024 global and Chinese Eye drop Liquid ma......
  • Global Contact Lenses and Solutions Market Analysis 2013-2018 and Forecast 2019-2024
    Published: 07-May-2019        Price: US 2980 Onwards        Pages: 93
    Summary The global Contact Lenses and Solutions market will reach xxx Million USD in 2019 and CAGR xx% 2019-2024. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Contact Lenses and Solutions by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are cov......
  • Global Latanoprost Industry Market Research Report
    Published: 02-May-2019        Price: US 2960 Onwards        Pages: 132
    The Latanoprost market revenue was xx.xx Million USD in 2014, grew to xx.xx Million USD in 2018, and will reach xx.xx Million USD in 2024, with a CAGR of x.x% during 2019-2024. Based on the Latanoprost industrial chain, this report mainly elaborates the definition, types, applications and major players of Latanoprost market in details. Deep analysis about market status (2014-2019), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs